IMTX
Price:
$9.78
Market Cap:
$1.14B
Immatics N.V. is a clinical-stage biopharmaceutical firm dedicated to discovering and advancing T-cell receptor (TCR) based immunotherapies aimed at combating cancer, primarily within the United States. Its therapeutic strategy centers on targeted immunotherapies for solid tumors, utilizing two distinct approaches: adoptive cell therapies (ACT) and antibody-like TCR Bispecifics. The company's ACTengine™ portfolio features several candidates in Phase I clinical trials. These include IMA201, designed to recognize melanoma-associated antigens 4 or 8 in solid tumor patients; IMA202, which targets melanoma-associated antigen 1 across various solid tumor types, such as squamous non-small cell lung...[Read more]
Industry
Biotechnology
IPO Date
2018-12-12
Stock Exchange
NASDAQ
Ticker
IMTX
According to Immatics N.V.’s latest financial reports and current stock price. The company's current ROE is -45.27%. This represents a change of 297.88% compared to the average of -11.38% of the last 4 quarters.
The mean historical ROE of Immatics N.V. over the last ten years is -37.56%. The current -45.27% ROE has changed 20.53% with respect to the historical average. Over the past ten years (40 quarters), IMTX's ROE was at its highest in in the March 2022 quarter at 73.85%. The ROE was at its lowest in in the September 2020 quarter at -145.58%.
Average
-37.56%
Median
-18.97%
Minimum
-395.05%
Maximum
302.14%
Discovering the peaks and valleys of Immatics N.V. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 79.58%
Maximum Annual ROE = 302.14%
Minimum Annual Increase = -1633.51%
Minimum Annual ROE = -395.05%
| Year | ROE | Change |
|---|---|---|
| 2025 | -40.60% | -1633.51% |
| 2024 | 2.65% | -106.14% |
| 2023 | -43.09% | -344.86% |
| 2022 | 17.60% | -104.45% |
| 2021 | -395.05% | 79.58% |
| 2020 | -219.99% | -390.08% |
| 2019 | 75.84% | -74.90% |
The current ROE of Immatics N.V. (IMTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-27.01%
5-year avg
-91.70%
10-year avg
-37.56%
Immatics N.V.’s ROE is greater than Inhibrx Biosciences, Inc. (-563.89%), greater than Enliven Therapeutics, Inc. (-21.04%), greater than Nektar Therapeutics (-87.00%), greater than Terns Pharmaceuticals, Inc. (-20.02%), greater than Tourmaline Bio, Inc. (-24.42%), greater than Relay Therapeutics, Inc. (-43.94%), greater than Syndax Pharmaceuticals, Inc. (-256.66%), greater than Atai Beckley Inc. (-366.49%), greater than Precigen, Inc. (-1768.51%), less than CureVac N.V. (18.40%),
| Company | ROE | Market cap |
|---|---|---|
| -563.89% | $1.37B | |
| -21.04% | $3.15B | |
| -87.00% | $1.19B | |
| -20.02% | $4.77B | |
| -24.42% | $1.23B | |
| -43.94% | $2.78B | |
| -256.66% | $1.68B | |
| -366.49% | $1.49B | |
| -1768.51% | $1.45B | |
| 18.40% | $1.05B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Immatics N.V. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Immatics N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Immatics N.V.'s ROE?
How is the ROE calculated for Immatics N.V. (IMTX)?
What is the highest ROE for Immatics N.V. (IMTX)?
What is the 3-year average ROE for Immatics N.V. (IMTX)?
What is the 5-year average ROE for Immatics N.V. (IMTX)?
How does the current ROE for Immatics N.V. (IMTX) compare to its historical average?